|
|
Post by travis1953 on Jan 21, 2019 12:22:05 GMT -5
www.richardcsinger.com/page-1
"VDEX seeking control of AFREZZA from MannKind via Royalty Agreement. As part of this strategy VDEX would be open to Equity Investors."
What is the royalty agreement to which it refers? Is it hinting that maybe Mannkind intends to sell afrezza altogether?
|
|
|
|
Post by mango on Jan 21, 2019 12:26:10 GMT -5
On November 9, 2018 three of my clients met in Las Vegas to discuss various Business Development opportunities. Hosted by Stop Pain Medicinals, Bob Hainey, also in attendance was Bill McCullough and Jeremy Fultz of VDEX Diabetes, Inc. and Rene and Cherie Ortiz-Morentin of Toron, Inc. (publicly traded symbol TRON) The Toron Subsidiary, InMedGroup Inc. also owns InMedScan, a proprietary electronic software (www.inmedscan.com) which they believe accelerates Insurance Payments for Healthcare Group Practitioners and can further increase sales and profitability for that subsidiary. Dr. Charles Walker, D.O., Medical Director of Stop Pain was also in attendance.
Both Stop Pain and VDEX are Medically Supervised protocols, Stop Pain addressing via its CBD products the Opioid crisis and Pain Management. They also have a CBD/Diabetic Cream for Neuropathy. Stop Pain is in the process of going Public and is finishing up its Web Site.
Here are some of the Pertinent Points Discussed:
1. Opening Medically Supervised Clinics with both the Stop Pain and VDEX protocols throughout the USA. Toron has verbally committed to do so in its facilities.
2. VDEX seeking control of AFREZZA from MannKind via Royalty Agreement. As part of this strategy VDEX would be open to Equity Investors.
3. Toron, Inc. has secured funding for the InMed Group and anticipates taking control of the facilities by January 1st. Additional Working Capital has been committed and Toron is already being approached by other Facilities to be acquired.
In Summary, this is an outstanding opportunity and I welcome your thoughts and feedback and how you might want to assist these companies in Business Development and Raise Capital .
|
|
|
|
Post by mnkdfann on Jan 21, 2019 13:12:21 GMT -5
www.richardcsinger.com/page-1
"VDEX seeking control of AFREZZA from MannKind via Royalty Agreement. As part of this strategy VDEX would be open to Equity Investors."
What is the royalty agreement to which it refers? Is it hinting that maybe Mannkind intends to sell afrezza altogether?
Looks like that came out of a brainstorming session at a small conference hosted by a sm allish Investor Relations group in a hotel (The Mirage ) in Vegas. It attracted 2 or 3 participants. My guess is that the IR group was trying to network companies and develop investable solutions it can make money off of (by doing the deal). Personally, I don't read much into it. VDEX is on this board, perhaps it / they will comment? |
|
|
|
Post by babaoriley on Jan 21, 2019 14:12:56 GMT -5
www.richardcsinger.com/page-1
"VDEX seeking control of AFREZZA from MannKind via Royalty Agreement. As part of this strategy VDEX would be open to Equity Investors."
What is the royalty agreement to which it refers? Is it hinting that maybe Mannkind intends to sell afrezza altogether?
I thought I saw that reported on BuzzFeed, but am not certain.... |
|
|
|
Post by sayhey24 on Jan 21, 2019 14:21:21 GMT -5
I think Richard Singer's top button may have been too tight and was blocking some blood flow www.richardcsinger.com/page-1It would be great to see VDex get properly funded. At this point IMO they are not which is why they have not opened full time walk in clinics. Bullet two - "VDEX seeking control of AFREZZA from MannKind via Royalty Agreement" I take as wishful thinking or one drink too many. |
|
|
|
Post by agedhippie on Jan 21, 2019 14:21:39 GMT -5
If it had been real then there would not have been the last cash raise because the last thing you would want to do is cut in another 40M shares into a deal. I feel that if the people behind that web site can buy Afrezza from Mannkind then we are all in trouble because they do not look like they have a lot of money.
|
|
|
|
Post by longliner on Jan 21, 2019 15:40:57 GMT -5
If it had been real then there would not have been the last cash raise because the last thing you would want to do is cut in another 40M shares into a deal. I feel that if the people behind that web site can buy Afrezza from Mannkind then we are all in trouble because they do not look like they have a lot of money. Yes, I'm far more interested in names like JNJ, Lilly, PFE, etc..... |
|
|
|
Post by vdexdiabetes on Jan 21, 2019 17:07:34 GMT -5
Mr. Singer does not speak for Vdex... But, an interesting idea nonetheless
|
|
|
|
Post by falconquest on Jan 21, 2019 17:58:49 GMT -5
I think it would be great for Mannkind to get out from under Afrezza. they would get the royalty payments and have the manufacturing without the added costs of trying to run a sales force and marketing. Al said that he saw Mannkind as a drug development company, not a pharma company. This would free up capital to explore other areas such as pain management.
|
|
|
|
Post by itellthefuture777 on Jan 21, 2019 18:11:33 GMT -5
I think it would be great for Mannkind to get out from under Afrezza. they would get the royalty payments and have the manufacturing without the added costs of trying to run a sales force and marketing. Al said that he saw Mannkind as a drug development company, not a pharma company. This would free up capital to explore other areas such as pain management. Afrezza..stays with us...next! |
|
